- £883.54m
- £1.46bn
- £2.05bn
- 37
- 42
- 64
- 43
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,140 | 1,614 | 2,180 | 2,239 | 2,045 |
Cost of Revenue | |||||
Gross Profit | 497 | 713 | 954 | 905 | 856 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,160 | 2,095 | 2,317 | 2,735 | 2,231 |
Operating Profit | -19.7 | -482 | -137 | -496 | -185 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -45.2 | -535 | -186 | -550 | -252 |
Provision for Income Taxes | |||||
Net Income After Taxes | -44.2 | -533 | -138 | -540 | -248 |
Net Income Before Extraordinary Items | |||||
Net Income | -44.2 | -533 | -138 | -540 | -248 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -44.2 | -533 | -138 | -540 | -248 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.012 | -0.424 | -0.019 | -0.187 | -0.141 |